Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Pemetrexed/Cisplatin/Radiation in Stage IIIA/B NSCLC
NCT00529100Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2005
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Dec 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00529100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529100.